Sprim Als Blog Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technology

BRISBANE, Australia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Vaxxas Pty Ltd, the biotechnology company pioneering the high-density microarray patch (HD-MAP) for needle-free vaccine delivery, today announced that it has secured ~$90 million in its latest financing round. The financing is ... Read More The post Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technology appeared first on SPRIM.